Breast Cancer Drug Studies Rife with Spin, Bias | GenomeWeb

Reports of breast cancer drug trials in the scientific literature are far from fair and balanced, according to researchers at the University of Toronto this week

The group published a study in Annals of Oncology yesterday showing that outcomes from phase III breast cancer trials are widely reported with both spin and bias.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.